Provided by Tiger Trade Technology Pte. Ltd.

InspireMD

0.6196
-0.0482-7.22%
Post-market: 0.61960.00000.00%16:10 EDT
Volume:86.92K
Turnover:56.51K
Market Cap:28.80M
PE:-0.96
High:0.7100
Open:0.7090
Low:0.6090
Close:0.6678
52wk High:2.57
52wk Low:0.6000
Shares:46.49M
Float Shares:34.07M
Volume Ratio:0.92
T/O Rate:0.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6464
EPS(LYR):-0.7584
ROE:-202.81%
ROA:-85.85%
PB:0.91
PE(LYR):-0.82

Loading ...

InspireMD (NASDAQ:NSPR) Will Have To Spend Its Cash Wisely

Simply Wall St.
·
Yesterday

InspireMD Cuts Warrant Exercise Price to USD 0.77, Extends Expiry to May 2028 or Post-FDA Approval Window

Reuters
·
Sep 22

InspireMD Amends Warrants to Support CGuard Prime Launch

TIPRANKS
·
Sep 21

InspireMD Announces Amendments to Certain Series J and Series K Warrants, Providing Potential Gross Proceeds of up to $11 Million

THOMSON REUTERS
·
Sep 21

InspireMD Announces Amendments to Certain Series J and Series K Warrants, Providing Potential Gross Proceeds of Up to $11 Million

GlobeNewswire
·
Sep 21

InspireMD Grants New Hire 23,764 Restricted Shares Under Inducement Plan

Reuters
·
Sep 05

InspireMD Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Sep 05

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Sep 05

InspireMD to Present at H.C. Wainwright Global Investment Conference

Reuters
·
Sep 03

InspireMD to Participate in Upcoming H.C. Wainwright 28th Annual Global Investment Conference

GlobeNewswire
·
Sep 03

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Atai Beckley N.V. (ATAI), InspireMD (NSPR) and Silexion Therapeutics (SLXN)

TIPRANKS
·
Aug 20

Iridex Q2 Revenue Falls as Retina Sales Decline

Reuters
·
Aug 19

Analysts Offer Insights on Healthcare Companies: Vivani Medical (VANI) and InspireMD (NSPR)

TIPRANKS
·
Aug 18

Sweden's OssDsign Q2 Sales Rise 2.4% Gross Margin Falls

Reuters
·
Aug 18

InspireMD (NSPR) Q2 2026 Earnings Call: Recall Impact and FDA Catalysts

TradingKey
·
Aug 18

InspireMD Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 17

ENDRA Life Sciences Posts Q2 Profit on Digital Asset Gains Ahead of Merger

Reuters
·
Aug 17

InspireMD Q2 Revenue Beats Estimates on International Demand

Reuters
·
Aug 17

InspireMD Q2 EPS $(0.17) Beats $(0.19) Estimate, Sales $1.771M Miss $2.133M Estimate

Benzinga Earnings
·
Aug 17

InspireMD Q2 Gross Profit USD -774 Thousand

THOMSON REUTERS
·
Aug 17